Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis

Pathology International

Volumn 48, Issue 12, 1998, Pages 954-963

  Yaguchi, Takamoto ^a,b   Fukuda, Yuh ^a   Ishizaki, Masamichi ^a   Yamanaka, Nobuaki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Bleomycin; Gelatin zymography; Matrix metalloproteinase; Pulmonary fibrosis; Tissue inhibitor of matrix metalloproteinase

Indexed keywords

BLEOMYCIN; COLLAGENASE; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG HOMOGENATE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RABBIT; ZYMOGRAPHY;

EID: 0032437893     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03866.x     Document Type: Article

References (33)

1. Basset F, Ferrans VJ, Soler P, Takemura T, Fukuda Y, Crystal RG. Intraluminal fibrosis in interstitial lung disorders. Am. J. Pathol. 1986; 122: 443-461.
2. Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis: Ultrastructural and immuno histochemical features of sites of active extracellular matrix synthesis. Am. J. Pathol. 1991; 138: 1257-1265.
3. Fukuda Y, Basset F, Soler P, Ferrans VJ, Masugi Y, Crystal RG. Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X). Am. J. Pathol. 1990; 137: 415-424.
4. Fukuda Y, Basset F, Ferrans VJ, Yamanaka N. Significance of early intra-alveolar fibrotic lesions and integrin expression in lung biopsy specimens from patients with idiopathic pulmonary fibrosis. Hum. Pathol. 1995; 26: 53-61.
5. Fukuda Y, Ferrans VJ, Schoenberger CI, Rennard SI, Crystal RG. Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. Am. J. Pathol. 1985; 118: 452-475.
6. Usuki J, Fukuda Y. Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats. Pathol. Int. 1995; 45: 552-564.
7. Woessner Jr JF. The family of matrix metalloproteinases. Ann. N.Y. Acad. Sci. 1994; 732: 11-21.
8. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 1997; 378: 151-160.
9. Matsumoto S, Katoh M, Watanabe T, Masuho Y. Molecular cloning of rabbit matrix metalloproteinase-2 and its broad expression at several tissues. Biochim. Biophys. Acta 1996; 1307: 137-139.
10. Pardo A, Selman M, Ramirez R et al. Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. Chest 1992; 102: 1085-1089.
11. Arden MG, Spearman MA, Adamson IY. Degradation of type IV collagen during the development of fetal rat lung. Am. J. Respir. Cell Mol. Biol. 1993; 9: 99-105.
12. D'Ortho MP, Jarreau PH, Delacourt C et al. Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. Am. J. Physiol. 1994; 266: L209-L216.
13. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin. Chim. Acta 1993; 219: 1-14.
14. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin. Chim. Acta 1993; 221: 91-103.
15. Fujimoto N, Hosokawa N, Iwata K, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 9 using monoclonal antibodies. Ann. N. Y. Acad. Sci. 1994; 732: 359-361.
16. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin. Chim. Acta 1993; 220: 31-45.
17. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 1985; 260: 2493-2500.
18. Kawanami O, Ferrans VJ, Crystal RG. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab. Invest. 1982; 46: 39-53.
19. Murphy G, Cockett MI, Ward RV, Docherty AJ. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 1991; 277: 277-279.
20. Okada Y, Gonoji Y, Naka K et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 1992; 267: 21 712-21 719.
21. Okada Y, Naka K, Kawamura K et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: Implications for bone resorption. Lab. Invest. 1995; 72: 311-322.
22. Ueda Y, Imai K, Tsuchiya H et al. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am. J. Pathol. 1996; 148: 611-622.
23. Sato H, Kita M, Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements: A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 1993; 268: 23 460-23 468.
24. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.
25. Asada K, Ogushi F, Tani K et al. The role of cell-associated interleukin-1 in bleomycin-induced pulmonary fibrosis. Tokushima J. Exp. Med. 1996; 43: 79-86.
26. Madtes DK, Busby HK, Strandjord TP, Clark JG. Expression of transforming growth factor-α and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am. J. Respir. Cell Mol. Biol. 1994; 11: 540-551.
27. Scheule RK, Perkins RC, Hamilton R, Holian A. Bleomycin stimulation of cytokine secretion by the human alveolar macrophage. Am. J. Physiol. 1992; 262: L386-L391.
28. Maeda A, Hiyama K, Yamakido H, Ishioka S, Yamakido M. Increased expression of platelet-derived growth factor A and insulin-like growth factor-1 in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest 1996; 109: 780-786.
29. Overall CM, Wrana JL, Sodek J. Transcriptional and posttranscriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts: Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem. 1991; 266: 14 064-14 071.
30. Santana A, Saxena B, Noble NA, Gold LI, Marshall BC. Increased expression of transforming growth factor-β isoforms (β1, β2, β3) in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 1995; 13: 34-44.
31. Kawamoto M, Fukuda Y. Cell proliferation during the process of bleomycin-induced pulmonary fibrosis in rats. Acta Pathol. Jpn. 1990; 40: 227-238.
32. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2 and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung disease. Lab. Invest. 1998; 78: 687-698.
33. Bigby TD, Allen D, Leslie CG, Henson PM, Cherniack RM. Bleomycin-induced lung injury in the rabbit: Analysis and correlation of bronchoalveolar lavage, morphometrics, and fibroblast stimulating activity. Am. Rev. Respir. Dis. 1985; 132: 590-595.